The Asia-Pacific cartilage degeneration market is set to register a CAGR of 4.87% over the projected years of 2021 to 2028. The increasing acceptance of sports among the younger generation, the rising expenditure on public health care systems, as well as the substantial surge in the geriatric populace, are among the key factors set to reinforce the market growth of the region.

ASIA-PACIFIC CARTILAGE DEGENERATION MARKET FORECAST 2021-2028

Asia-Pacific Cartilage Degeneration Market by Procedure (Joint Replacement, Chondroplasty, Cell-based Cartilage Resurfacing, Osteochondral Transplant, Meniscus Transplants, Other Procedures) Market by Application (Knee, Hips, Other Applications) Market by End-user (Ambulatory Surgical Centers, Hospitals & Specialty Clinics, Academic & Research Institutes) by Geography

Request free sample

Report Summary

To learn more about this report, request a free sample copy

The Asia-Pacific cartilage degeneration market growth evaluation constitutes the in-depth analysis of Singapore, Australia & New Zealand, Thailand, South Korea, India, China, Japan, Indonesia, and the rest of the Asia-Pacific. China is the largest market for cartilage degeneration across the Asia-Pacific. The country’s market growth is facilitated by favorable regulatory policies, the developments initiated by market players, and the surging adoption of advanced technology. Furthermore, China’s extensive population base, including the elderly, plays a key role in fueling the market demand in the country.

On the other hand, the cartilage degeneration market in Japan observes an exponentially growing trend, accredited to the well-established presence of domestic players, in addition to international companies in the country. For example. Japan Tissue Engineering of the Fujifilm Group commercialized regenerative medicine comprising the transplant of a patient’s cultured cells in order to restore the damaged cartilage of the knee. Thus, these drivers are expected to augment the market growth in the Asia-Pacific during the forecasting period.

Stryker Corporation, headquartered in the United States, is a medical technology company offering a diverse range of innovative services and products in medical and surgical, orthopedics, and neurotechnology. The company’s top products entail surgical navigation systems, intensive care disposable products, neurovascular and spinal devices, emergency medical equipment, endoscopic and communications systems, and others. It operates in the United States, Asia-Pacific, the Middle East and Africa, Latin America, and Canada.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
MARKET DYNAMICS
- KEY DRIVERS
  - SPORTS INJURIES DAMAGING CARTILAGE AND LIGAMENTS
  - DEGENERATION OF CARTILAGE DUE TO OBESITY
  - BONE AND JOINT-RELATED DISEASES IN THE GERIATRIC POPULATION
- KEY RESTRAINTS
  - HIGH COST OF CARTILAGE REPAIR THERAPIES

KEY ANALYTICS
- IMPACT OF COVID-19 ON CARTILAGE DEGENERATION MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
  - THREAT OF NEW ENTRY
  - THREAT OF SUBSTITUTION
  - BUYERS POWER
  - SUPPLIERS POWER
  - COMPETITIVE RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
MARKET BY PROCEDURE
- JOINT REPLACEMENT
- CHONDROPLASTY
- CELL-BASED CARTILAGE RESURFACING
- OSTEOCHONDRAL TRANSPLANT
- MENISCUS TRANSPLANTS
- OTHER PROCEDURES
MARKET BY APPLICATION
- KNEE
- HIPS
- OTHER APPLICATIONS
MARKET BY END-USER
- AMBULATORY SURGICAL CENTERS
- HOSPITALS & SPECIALTY CLINICS
- ACADEMIC & RESEARCH INSTITUTES
GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
  - MARKET SIZE & ESTIMATES
  - KEY GROWTH ENABLERS
  - KEY CHALLENGES
  - KEY PLAYERS
  - COUNTRY ANALYSIS
    - CHINA
    - JAPAN
    - AUSTRALIA & NEW ZEALAND
    - INDIA
    - SOUTH KOREA
    - THAILAND
    - SINGAPORE
    - INDONESIA
    - REST OF ASIA-PACIFIC

COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
  - MERGERS & ACQUISITIONS
  - PRODUCT LAUNCHES & DEVELOPMENTS
  - PARTNERSHIPS & AGREEMENTS
  - BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
- COMPANY PROFILES
  - ANIKA THERAPEUTICS INC
  - ARTHREX INC
  - B BRAUN MELSUNGEN AG
  - BIOTISSUE SA
  - CARTIHEAL INC
  - CONMED CORPORATION
  - DEPUY SYNTHES COMPANIES
  - OSIRIS THERAPEUTICS INC
  - RTI SURGICAL INC
  - SMITH & NEPHEW PLC
  - STRYKER CORPORATION
  - VERICEL CORPORATION
  - ZIMMER BIOMET HOLDINGS

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – CARTILAGE DEGENERATION

TABLE 2: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY PROCEDURE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY PROCEDURE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: LEADING PLAYERS OPERATING IN THE ASIA-PACIFIC CARTILAGE DEGENERATION MARKET

TABLE 11: LIST OF MERGERS & ACQUISITIONS

TABLE 12: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 14: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCE ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY PROCEDURE, IN 2020

FIGURE 6: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY JOINT REPLACEMENT, 2021-2028 (IN $ MILLION)

FIGURE 7: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY CHONDROPLASTY, 2021-2028 (IN $ MILLION)

FIGURE 8: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY CELL-BASED CARTILAGE RESURFACING, 2021-2028 (IN $ MILLION)

FIGURE 9: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY OSTEOCHONDRAL TRANSPLANT, 2021-2028 (IN $ MILLION)

FIGURE 10: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY MENISCUS TRANSPLANTS, 2021-2028 (IN $ MILLION)

FIGURE 11: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY OTHER PROCEDURES, 2021-2028 (IN $ MILLION)

FIGURE 12: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY APPLICATION, IN 2020

FIGURE 13: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY KNEE, 2021-2028 (IN $ MILLION)

FIGURE 14: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY HIPS, 2021-2028 (IN $ MILLION)

FIGURE 15: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 16: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY END-USER, IN 2020

FIGURE 17: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)

FIGURE 18: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY HOSPITALS & SPECIALTY CLINICS, 2021-2028 (IN $ MILLION)

FIGURE 19: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, BY ACADEMIC & RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)

FIGURE 20: ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 21: CHINA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

FIGURE 22: JAPAN CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

FIGURE 23: AUSTRALIA & NEW ZEALAND CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

FIGURE 24: INDIA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

FIGURE 25: SOUTH KOREA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

FIGURE 26: THAILAND CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

FIGURE 27: SINGAPORE CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

FIGURE 28: INDONESIA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

FIGURE 29: REST OF ASIA-PACIFIC CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

Segmentation

GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
  - MARKET SIZE & ESTIMATES
  - KEY GROWTH ENABLERS
  - KEY CHALLENGES
  - KEY PLAYERS
  - COUNTRY ANALYSIS
    - CHINA
    - JAPAN
    - AUSTRALIA & NEW ZEALAND
    - INDIA
    - SOUTH KOREA
    - THAILAND
    - SINGAPORE
    - INDONESIA
    - REST OF ASIA-PACIFIC

MARKET BY PROCEDURE
- JOINT REPLACEMENT
- CHONDROPLASTY
- CELL-BASED CARTILAGE RESURFACING
- OSTEOCHONDRAL TRANSPLANT
- MENISCUS TRANSPLANTS
- OTHER PROCEDURES
MARKET BY APPLICATION
- KNEE
- HIPS
- OTHER APPLICATIONS
MARKET BY END-USER
- AMBULATORY SURGICAL CENTERS
- HOSPITALS & SPECIALTY CLINICS
- ACADEMIC & RESEARCH INSTITUTES

Request Free Sample

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.